BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 30277494)

  • 1. Xanthine Oxidase Inhibitor, Febuxostat Ameliorates the High Salt Intake-Induced Cardiac Hypertrophy and Fibrosis in Dahl Salt-Sensitive Rats.
    Namai-Takahashi A; Sakuyama A; Nakamura T; Miura T; Takahashi J; Kurosawa R; Kohzuki M; Ito O
    Am J Hypertens; 2019 Jan; 32(1):26-33. PubMed ID: 30277494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Xanthine oxidase inhibitor febuxostat reduces atrial fibrillation susceptibility by inhibition of oxidized CaMKII in Dahl salt-sensitive rats.
    Xu D; Murakoshi N; Tajiri K; Duo F; Okabe Y; Murakata Y; Yuan Z; Li S; Aonuma K; Song Z; Shimoda Y; Mori H; Sato A; Nogami A; Aonuma K; Ieda M
    Clin Sci (Lond); 2021 Oct; 135(20):2409-2422. PubMed ID: 34386810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High Salt Intake-Increased (Pro)renin Receptor Expression Is Exaggerated in the Kidney of Dahl Salt-Sensitive Rats.
    Yamakoshi S; Ito O; Rong R; Ohsaki Y; Nakamura T; Hirose T; Takahashi K; Mori T; Totsune K; Kohzuki M
    Hypertension; 2020 Jun; 75(6):1447-1454. PubMed ID: 32336231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardioprotective mechanism of telmisartan via PPAR-gamma-eNOS pathway in dahl salt-sensitive hypertensive rats.
    Kobayashi N; Ohno T; Yoshida K; Fukushima H; Mamada Y; Nomura M; Hirata H; Machida Y; Shinoda M; Suzuki N; Matsuoka H
    Am J Hypertens; 2008 May; 21(5):576-81. PubMed ID: 18437150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of xanthine oxidoreductase in the reversal of diastolic heart failure by candesartan in the salt-sensitive hypertensive rat.
    Yamamoto E; Kataoka K; Yamashita T; Tokutomi Y; Dong YF; Matsuba S; Ogawa H; Kim-Mitsuyama S
    Hypertension; 2007 Oct; 50(4):657-62. PubMed ID: 17709654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal Antibody to Marinobufagenin Downregulates TGFβ Profibrotic Signaling in Left Ventricle and Kidney and Reduces Tissue Remodeling in Salt-Sensitive Hypertension.
    Zhang Y; Wei W; Shilova V; Petrashevskaya NN; Zernetkina VI; Grigorova YN; Marshall CA; Fenner RC; Lehrmann E; Wood WH; Becker KG; Lakatta EG; Bagrov AY; Fedorova OV
    J Am Heart Assoc; 2019 Oct; 8(20):e012138. PubMed ID: 31576777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of reactive oxygen species to the pathogenesis of left ventricular failure in Dahl salt-sensitive hypertensive rats: effects of angiotensin II blockade.
    Guo P; Nishiyama A; Rahman M; Nagai Y; Noma T; Namba T; Ishizawa M; Murakami K; Miyatake A; Kimura S; Mizushige K; Abe Y; Ohmori K; Kohno M
    J Hypertens; 2006 Jun; 24(6):1097-104. PubMed ID: 16685210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attenuation of ventricular hypertrophy and fibrosis in rats by pitavastatin: potential role of the RhoA-extracellular signal-regulated kinase-serum response factor signalling pathway.
    Saka M; Obata K; Ichihara S; Cheng XW; Kimata H; Noda A; Izawa H; Nagata K; Yokota M
    Clin Exp Pharmacol Physiol; 2006 Dec; 33(12):1164-71. PubMed ID: 17184496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benidipine inhibits expression of ET-1 and TGF-beta1 in Dahl salt-sensitive hypertensive rats.
    Kobayashi N; Nakano S; Mori Y; Kobayashi T; Tsubokou Y; Matsuoka H
    Hypertens Res; 2001 May; 24(3):241-50. PubMed ID: 11409647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of ACE inhibition on left ventricular failure and oxidative stress in Dahl salt-sensitive rats.
    Tsutsui H; Ide T; Hayashidani S; Kinugawa S; Suematsu N; Utsumi H; Takeshita A
    J Cardiovasc Pharmacol; 2001 Jun; 37(6):725-33. PubMed ID: 11392469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nicotinamide adenine dinucleotide phosphate oxidase 4 mediates the differential responsiveness of atrial versus ventricular fibroblasts to transforming growth factor-β.
    Yeh YH; Kuo CT; Chang GJ; Qi XY; Nattel S; Chen WJ
    Circ Arrhythm Electrophysiol; 2013 Aug; 6(4):790-8. PubMed ID: 23884197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardioprotective mechanisms of Rho-kinase inhibition associated with eNOS and oxidative stress-LOX-1 pathway in Dahl salt-sensitive hypertensive rats.
    Mita S; Kobayashi N; Yoshida K; Nakano S; Matsuoka H
    J Hypertens; 2005 Jan; 23(1):87-96. PubMed ID: 15643129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac hypertrophy and cardiac renin-angiotensin system in Dahl rats on high salt intake.
    Zhao X; White R; Van Huysse J; Leenen FH
    J Hypertens; 2000 Sep; 18(9):1319-26. PubMed ID: 10994763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Febuxostat ameliorates high salt intake-induced hypertension and renal damage in Dahl salt-sensitive rats.
    Miura T; Sakuyama A; Xu L; Qiu J; Namai-Takahashi A; Ogawa Y; Kohzuki M; Ito O
    J Hypertens; 2022 Feb; 40(2):327-337. PubMed ID: 34495901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blockade of PAR-1 Signaling Attenuates Cardiac Hypertrophy and Fibrosis in Renin-Overexpressing Hypertensive Mice.
    Yokono Y; Hanada K; Narita M; Tatara Y; Kawamura Y; Miura N; Kitayama K; Nakata M; Nozaka M; Kato T; Kudo N; Tsushima M; Toyama Y; Itoh K; Tomita H
    J Am Heart Assoc; 2020 Jun; 9(12):e015616. PubMed ID: 32495720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardioprotective mechanisms of spironolactone associated with the angiotensin-converting enzyme/epidermal growth factor receptor/extracellular signal-regulated kinases, NAD(P)H oxidase/lectin-like oxidized low-density lipoprotein receptor-1, and Rho-kinase pathways in aldosterone/salt-induced hypertensive rats.
    Nakano S; Kobayashi N; Yoshida K; Ohno T; Matsuoka H
    Hypertens Res; 2005 Nov; 28(11):925-36. PubMed ID: 16555582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salutary effect of kallistatin in salt-induced renal injury, inflammation, and fibrosis via antioxidative stress.
    Shen B; Hagiwara M; Yao YY; Chao L; Chao J
    Hypertension; 2008 May; 51(5):1358-65. PubMed ID: 18391098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic effects of angiotensin II type 1 receptor blocker at an advanced stage of hypertensive diastolic heart failure.
    Nishio M; Sakata Y; Mano T; Yoshida J; Ohtani T; Takeda Y; Miwa T; Masuyama T; Yamamoto K; Hori M
    J Hypertens; 2007 Feb; 25(2):455-61. PubMed ID: 17211254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Xanthine Oxidase Inhibition by Febuxostat in Macrophages Suppresses Angiotensin II-Induced Aortic Fibrosis.
    Kondo M; Imanishi M; Fukushima K; Ikuto R; Murai Y; Horinouchi Y; Izawa-Ishizawa Y; Goda M; Zamami Y; Takechi K; Chuma M; Ikeda Y; Fujino H; Tsuchiya K; Ishizawa K
    Am J Hypertens; 2019 Feb; 32(3):249-256. PubMed ID: 30351343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A dipeptidyl peptidase-IV inhibitor improves diastolic dysfunction in Dahl salt-sensitive rats.
    Nakajima Y; Ito S; Asakura M; Min KD; Fu HY; Imazu M; Hitsumoto T; Takahama H; Shindo K; Fukuda H; Yamazaki S; Asanuma H; Kitakaze M
    J Mol Cell Cardiol; 2019 Apr; 129():257-265. PubMed ID: 30880253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.